TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/6/24 16:17 | 6/4/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -67 | 5.50 | 0 | -12 | -4 | 315 | D | ||||||||||||||
3/5/24 20:00 | 3/5/24 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S.d | -733 | 9.42 | 0 | -78 | -19 | 327 | D | ||||||||||||||
6/7/23 16:30 | 6/5/23 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | S | -62 | 9.50 | 0 | -6 | -5 | 130 | D | ||||||||||||||
5/24/19 20:07 | 5/23/19 | SRPT | Sarepta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | O'Neill Gilmore Neil | MA | O | EVP,R,D, | M.d | 0 | 0.00 | 0 | 12 | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |